1. Home
  2. AFMD vs BOSC Comparison

AFMD vs BOSC Comparison

Compare AFMD & BOSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • BOSC
  • Stock Information
  • Founded
  • AFMD 2000
  • BOSC 1990
  • Country
  • AFMD Germany
  • BOSC Israel
  • Employees
  • AFMD N/A
  • BOSC N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • BOSC Computer Communications Equipment
  • Sector
  • AFMD Health Care
  • BOSC Telecommunications
  • Exchange
  • AFMD Nasdaq
  • BOSC Nasdaq
  • Market Cap
  • AFMD 17.5M
  • BOSC 19.7M
  • IPO Year
  • AFMD 2014
  • BOSC 1996
  • Fundamental
  • Price
  • AFMD $1.15
  • BOSC $3.79
  • Analyst Decision
  • AFMD Strong Buy
  • BOSC Strong Buy
  • Analyst Count
  • AFMD 5
  • BOSC 1
  • Target Price
  • AFMD $13.50
  • BOSC $5.00
  • AVG Volume (30 Days)
  • AFMD 363.4K
  • BOSC 63.1K
  • Earning Date
  • AFMD 11-14-2024
  • BOSC 11-27-2024
  • Dividend Yield
  • AFMD N/A
  • BOSC N/A
  • EPS Growth
  • AFMD N/A
  • BOSC 5.81
  • EPS
  • AFMD N/A
  • BOSC 0.38
  • Revenue
  • AFMD $6,287,085.00
  • BOSC $40,448,000.00
  • Revenue This Year
  • AFMD N/A
  • BOSC $6.20
  • Revenue Next Year
  • AFMD $212.48
  • BOSC N/A
  • P/E Ratio
  • AFMD N/A
  • BOSC $9.97
  • Revenue Growth
  • AFMD N/A
  • BOSC N/A
  • 52 Week Low
  • AFMD $1.03
  • BOSC $2.50
  • 52 Week High
  • AFMD $8.95
  • BOSC $4.20
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 28.57
  • BOSC 62.05
  • Support Level
  • AFMD $1.03
  • BOSC $3.43
  • Resistance Level
  • AFMD $1.41
  • BOSC $3.78
  • Average True Range (ATR)
  • AFMD 0.11
  • BOSC 0.25
  • MACD
  • AFMD 0.05
  • BOSC 0.02
  • Stochastic Oscillator
  • AFMD 23.53
  • BOSC 60.85

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

Share on Social Networks: